Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis

Haematologica

Volumn 94, Issue 5, 2009, Pages 712-719

  Gurion, Ronit ^a,b   Gafter Gvili, Anat ^a,b   Paul, Mical ^b   Vidal, Liat ^a,b   Ben Bassat, Isaac ^b   Yeshurun, Moshe ^a,b   Shpilberg, Ofer ^a,b   Raanani, Pia ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aplastic anemia; Hematopoietic growth factors; Immunosuppressive therapy

Indexed keywords

CYCLOSPORIN A; HEMOPOIETIC GROWTH FACTOR; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; META ANALYSIS; MORTALITY; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; RELAPSE; SYSTEMATIC REVIEW;

ANEMIA, APLASTIC; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 66049129912     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.002170     Document Type: Article

References (48)

1. Brodsky RA. Biology and management of acquired severe aplastic anemia. Curr Opin Oncol 1998;10:95-99 (Pubitemid 28138308)
2. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976;48:63-70.
3. Bacigalupo A, Bruno B, Saracco P, Di BE, Locasciulli A, Locatelli F, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midollo Osseo (GITMO). Blood 2000;95:1931-1934.
4. Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000;96:2049-2054
5. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003;123:782-801.
6. Storb R, Longton G, Anasetti C, Appelbaum FR, Beatty P, Bensinger W, et al. Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant 1992;10 (Suppl 1):45-52.
7. Imashuku S, Hibi S, Bessho F, Tsuchida M, Nakahata T, Miyazaki S, et al. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF. Haematologica 2003; 88:e136-e141.
8. Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al. Longterm outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004;103:2490-2497
9. Vadhan-Raj S, Broxmeyer HE, Hittelman WN. Use of granulocytemacrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response. Semin Hematol 1992;29:4-13.
10. Hord JD, Gay JC, Whitlock JA, Janco RL, Edwards JR, Greer JP, et al. Longterm granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J Pediatr Hematol Oncol 1995; 17:140-144
11. Locasciulli A, Arcese W, Locatelli F, Di Bona E, Bacigalupo A. Treatment of aplastic anaemia with granulocyte- colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 2001; 357:43-44
12. Symeonidis A, Kouraklis- Symeonidis A, Seimeni U, Galani A, Giannakoulas N, Fragopanagou E, et al. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases. Am J Hematol 2002;71:24-32.
13. Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, et al. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood 1996;87:4076-4081 (Pubitemid 26152251)
14. Blackwell S, Crawford J. Colonys-timulating factors: clinical applications. Pharmacotherapy 1992;12: 20S-31S.
15. Yoshida Y, Asano S, Hirashima K, Takaku F. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS). J Nutr Sci Vitaminol Tokyo 1992; Spec No:349-352
16. Gluckman E, Rokicka-Milewska R, Hann I, Nikiforakis E, Tavakoli F, Cohen-Scali S, et al. Results and follow- up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol 2002;119: 1075-1082
17. Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 2006; 34:826-831 (Pubitemid 43949184)
18. Gluckman E, Bourdeau-Esperou H, Boogaerts M, Briere J, Navarro J, Leverger G, et al. New approach of treatment of severe aplastic anemia. Cooperative Group on the Treatment of Aplastic Anemia. Bone Marrow Transplant 1991;7(Suppl 2):106-107
19. Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002;100:786-790
20. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Chichester, UK: John Wiley & Sons, Ltd. 2006.
21. DerSimonian R, Laird N. Metaanalysis in clinical trials. Control Clin Trials 1986;7:177-188
22. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colonys-timulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995;85: 1348-1353
23. Dincol G, Aktan M, Diz-Kucukkaya R, Yavuz S, Nalcaci M, Ozturk S, et al. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor. Am J Hematol 2007;82:783-786 (Pubitemid 350194505)
24. Jeng MR, Naidu PE, Rieman MD, Rodriguez-Galindo C, Nottage KA, Thornton DT, et al. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Pediatr Blood Cancer 2005;45:170-175
25. Socie G, Mary JY, Schrezenmeier H, Marsh J, Bacigalupo A, Locasciulli A, et al. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 2007;109:2794-2796
26. Vadhan-Raj S. Clinical trials of granulocyte- macrophage colony-stimulating factor for the treatment of aplastic anemia. Immunol Ser 1992; 57:661-670
27. Fuhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka- Schaub G, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 2005;106: 2102-2104
28. Bessho M, Hirashima K, Asano S, Ikeda Y, Ogawa N, Tomonaga M, et al. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colonys-timulating factor: a multicenter randomized controlled study. Multicenter Study Group. Eur J Haematol 1997;58:265-272
29. Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR, et al. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 1992;79:2566-2571
30. Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, et al. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Haematologica 2004;89:1054-1061
31. He G, Shao Z, Zhang Y, Liu H, Li K, Song L, et al. [Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia]. Zhonghua Xue Ye Xue Za Zhi 2001;22:177-181
32. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 2007; 110:1756-1761
33. Gordon-Smith EC, Yandle A, Milne A, Speck B, Marmont A, Willemze R, et al. Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia. Bone Marrow Transplant 1991;7(Suppl 2):78-80.
34. Shao Z, Chu Y, Zhang Y, Chen G, Zheng Y. Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colonystimulating factor and erythropoietin. Am J Hematol 1998;59:185-191 (Pubitemid 28485498)
35. th Annual Meeting of the European Group for Blood and Marrow Transplantation, Florence, Italy. 2008.
36. de Planque MM, Kluin-Nelemans HC, van Krieken HJ, Kluin PM, Brand A, Beverstock GC, et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 1988;70:55-62.
37. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993;329:1152-1157 (Pubitemid 23295457)
38. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol 1988;69: 413-418 (Pubitemid 18189995)
39. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol 1995;91:612-617
40. Kaito K, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Nishiwaki K, et al. [RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF]. Rinsho Ketsueki 1995;36:365-370
41. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997;90:1009-1013
42. Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628-4635
43. Geary CG, Harrison CJ, Philpott NJ, Hows JM, Gordon-Smith EC, Marsh JC. Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. Br J Haematol 1999;104: 271-274 (Pubitemid 29083333)
44. Piaggio G, Podesta M, Pitto A, Sessarego M, Figari O, Fugazza G, et al. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy. Br J Haematol 1999;107:505-511
45. Lowenberg B, Dale DC, Sheridan WP. Clinical use of hematopoietic growth factors. Rev Invest Clin 1994;Suppl:33-40.
46. Kim S, Saunthararajah Y, Block AW, Barrett J, Young NS, Sloand EM. Appearance of monosomy 7 in cultures of bone marrow cells from patients with myelodysplasia after exposure in vitro to granulocytecolony stimulating factor (G-CSF). Blood 2000;96:354A.
47. Marsh J. Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program 2006;78-85.
48. Tichelli A, Passweg J, Nissen C, Bargetzi M, Hoffmann T, Wodnar- Filipowicz A, et al. Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol 1998;100:393-400.